We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$18B
AUM Growth
+$622M
Cap. Flow
+$255M
Cap. Flow %
1.42%
Top 10 Hldgs %
56.54%
Holding
1,178
New
153
Increased
440
Reduced
373
Closed
159

Top Sells

Rank Stock Value
1
CCJ icon
Cameco
CCJ
+$31.7M
2
UUUU icon
Energy Fuels
UUUU
+$26.2M
3
NEM icon
Newmont
NEM
+$24.4M
4
LYB icon
LyondellBasell Industries
LYB
+$22.6M
5
MSM icon
MSC Industrial Direct
MSM
+$20.5M

Sector Composition

Rank Sector Weight
1 Energy 65.77%
2 Materials 4.62%
3 Technology 4.08%
4 Financials 3.42%
5 Consumer Discretionary 3.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIR icon
926
Vir Biotechnology
VIR
$1.47B
$377K ﹤0.01%
66,109
-8,441
-11% -$43.2K
EAT icon
927
Brinker International
EAT
$8.02B
$375K ﹤0.01%
2,963
+392
+15% +$61.2K
WFC icon
928
Wells Fargo
WFC
$261B
$372K ﹤0.01%
4,441
-1,360
-23% -$110K
ATLC icon
929
Atlanticus Holdings
ATLC
$1.5B
$370K ﹤0.01%
+6,320
New +$382K
SFM icon
930
Sprouts Farmers Market
SFM
$7.04B
$365K ﹤0.01%
3,353
+772
+30% +$112K
CART icon
931
Maplebear
CART
$9.92B
$362K ﹤0.01%
+9,840
New +$453K
IDT icon
932
IDT Corp
IDT
$1.6B
$359K ﹤0.01%
+6,870
New +$428K
MAZE
933
Maze Therapeutics
MAZE
$1.53B
$356K ﹤0.01%
13,742
-9,835
-42% -$166K
TBPH icon
934
Theravance Biopharma
TBPH
$874M
$354K ﹤0.01%
24,214
-2,793
-10% -$35.3K
HCA icon
935
HCA Healthcare
HCA
$84.8B
$347K ﹤0.01%
815
DAWN
936
DELISTED
Day One Biopharmaceuticals
DAWN
$346K ﹤0.01%
49,035
-5,673
-10% -$39K
TYRA icon
937
Tyra Biosciences
TYRA
$1.82B
$346K ﹤0.01%
24,700
-4,029
-14% -$45.9K
KURA icon
938
Kura Oncology
KURA
$922M
$345K ﹤0.01%
38,982
-7,678
-16% -$54.7K
AON icon
939
Aon
AON
$77.3B
$344K ﹤0.01%
966
-8,482
-90% -$3.07M
AKBA icon
940
Akebia Therapeutics
AKBA
$327M
$344K ﹤0.01%
126,061
-15,603
-11% -$51.9K
PVLA
941
Palvella Therapeutics
PVLA
$1.98B
$344K ﹤0.01%
+5,486
New +$245K
AVXL icon
942
Anavex Life Sciences
AVXL
$222M
$344K ﹤0.01%
38,606
-7,474
-16% -$75.8K
INDA icon
943
iShares MSCI India ETF
INDA
$6.65B
$339K ﹤0.01%
6,504
+1,265
+24% +$67.7K
ODFL icon
944
Old Dominion Freight Line
ODFL
$48.5B
$338K ﹤0.01%
2,404
-2,188
-48% -$335K
IQV icon
945
IQVIA
IQV
$34.7B
$335K ﹤0.01%
1,764
FLGT icon
946
Fulgent Genetics
FLGT
$559M
$329K ﹤0.01%
14,539
-1,873
-11% -$38.6K
UPBD icon
947
Upbound Group
UPBD
$1.19B
$323K ﹤0.01%
13,657
TERN
948
DELISTED
Terns Pharmaceuticals
TERN
$320K ﹤0.01%
42,630
-4,526
-10% -$28.9K
OLMA icon
949
Olema Pharmaceuticals
OLMA
$1.02B
$318K ﹤0.01%
32,510
-4,400
-12% -$26.4K
PLYM
950
DELISTED
Plymouth Industrial REIT
PLYM
$316K ﹤0.01%
14,145
-1,558
-10% -$28.6K

Similar funds

ALPS Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, ALPS Advisors held 1,178 positions worth $18B, up 3.6% from $17.3B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

ALPS Advisors's Q3 2025 filing shows 153 new, 440 increased, 373 reduced and 159 closed positions. Its largest new stake was LKQ Corp: 616,648 shares worth $18.8M. The largest sale was Cameco, an estimated $31.7M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 68% a quarter earlier, followed by Materials and Technology.

  • ALPS Advisors's largest Q3 2025 buy was LKQ Corp: 616,648 shares worth $18.8M.
  • ALPS Advisors added most to Energy Transfer Partners in Q3 2025, an estimated $59M increase.
  • ALPS Advisors's biggest Q3 2025 reduction was Cameco, cutting an estimated $31.7M.
  • ALPS Advisors fully exited LyondellBasell Industries in Q3 2025, selling an estimated $22.6M.
  • ALPS Advisors's ten largest holdings make up 57% of its $18B portfolio in Q3 2025.
  • ALPS Advisors opened 153 new positions and closed 159 in Q3 2025.
  • ALPS Advisors's portfolio value rose 3.6% quarter-over-quarter to $18B.

Based on ALPS Advisors's 13F filing for Q3 2025, filed 5 Nov 2025.